Omicron: What We Know, What We Don't Know, and What We Need to Know

As immunosuppressive therapies for cancer and autoimmune disease become more common, secondary immune deficiency is increasingly encountered in clinical practice. In this episode, Sara Barmettler, MD,...

6 Tammi 33min

Join hereditary angioedema expert Aleena Banerji, MD, FAAAAI, for a discussion about the diagnosis and management of hereditary angioedema, focusing on treatment developments that have dramatically im...

16 Joulu 202535min

Diagnosing Food Protein Induced Enterocolitis Syndrome (FPIES) can be challenging and once diagnosed, there are few options for treatment other than strict avoidance and waiting for resolution. Sara A...

2 Joulu 202543min

How do families know when to give epinephrine and when to go to the ER? How long do we need to observe after an episode of anaphylaxis and who is at risk for recurrent symptoms? We discuss these impor...

18 Marras 202550min

From now until December 31, 2025, AAAAI Fellows (those who have achieved the FAAAAI credential) and full members will select the next Board of Directors, including the next Secretary-Treasurer who wil...

3 Marras 202531min

Advising our families with food allergies as they navigate kids in school, holidays, introduction of foods in siblings, etc., can be challenging. Michael Pistiner, MD, MMSc, joins us to talk about res...

21 Loka 202545min

Latex Allergy has become much less common over the past two decades thanks to widespread changes in healthcare practices but still remains essential to recognize when present. Jay Slater, MD, discusse...

7 Loka 202543min

Drug allergy expert David Khan, MD, FAAAAI, discusses the importance of evaluating patients with reported penicillin allergy and how allergists can partner with other healthcare providers to make sure...

23 Syys 202548min